Sustainability Disclosures | Takeda Pharmaceuticals

Sustainability Disclosures

Building with solar panels

Our ESG reporting is updated regularly aligned with our transparency polices, practices, and data.

We will continuously work to improve our data capture processes and reporting of ESG information, to demonstrate our commitment to transparency and our stakeholders.

solar panels

We developed our corporate philosophy imperatives: Patient, People and Planet, which identify where Takeda must invest to deliver on our purpose, informed by an ESG materiality assessment of strategically important nonfinancial issues to our company and stakeholders. In FY2022, we evolved these imperatives to create a simplified sustainability framework and sustainability focus areas.

We measure our progress toward these imperatives and sustainability focus areas through our corporate philosophy metrics.

The information below provide links to our ESG disclosures and performance indicators under the categories of Patient, People, Planet and Values-Based Governance.

This information supplements our Annual Integrated Report.  A complete list of the Metrics under each category can be found here.


Responsibly translate science into highly innovative, life-transforming medicines and vaccines

Accelerate access to improve lives worldwide


Values-based governance